Top

The International Journal of Cardiovascular Imaging

Published in:

01-09-2016 | Original Paper

Echocardiographic outcomes of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN XT valves: the comparison of two bioprosthesis implanted in a single centre

Authors: Dayimi Kaya, Zulkif Tanriverdi, Huseyin Dursun, Tugce Colluoglu

Published in: The International Journal of Cardiovascular Imaging | Issue 9/2016

Abstract

Transcatheter aortic valve implantation (TAVI) with self-expandable Medtronic CoreValve (MCV; Medtronic, Minneapolis, MN) or balloon-expandable Edwards SAPIEN XT valve (ESV; Edwards Lifesciences, Irvine, CA) has been widely used for treatment of high-risk patients with severe aortic stenosis (AS). There is limited data comparing the long-term hemodynamic performance of these two valves. Therefore, this study aimed to compare the short and long-term hemodynamic performance of TAVI with either MCV or ESV. A total of 78 patients who underwent TAVI in our center between June 01, 2012 and January 01, 2014 were enrolled in this retrospective study. For each of the patients we recorded the preprocedural echocardiographic data as well as the post-TAVI echocardiographic outcomes at day one, 6 months and 1 year. The MCV group had lower transaortic gradients than the ESV group, with respect to both maximum (13.4 ± 5.8 vs 18.7 ± 8.1 mmHg, p = 0.001) and mean values (6.5 ± 3.2 vs 9.4 ± 4.3 mmHg, p < 0.001) at post-TAVI day one. These values continued to be significantly lower in the MCV group during post-TAVI 6 months (p < 0.001) and post-TAVI 1 year follow-up (p < 0.05). A paravalvular leak (PVL, grade ≥2) was observed in 6.4 % of patients after TAVI; however, this value decreased over time, and there was no significant difference between the MVC and ESV groups (8.2 vs 3.4 %, p = 0.646). The MCV bioprosthesis was associated with lower transaortic gradients than those of the ESV throughout 1 year of follow-up. The incidence of PVL grade ≥2 in MCV and ESV was comparable.

Leon MB, Smith CR, Mack M et al; PARTNER Trial Investigators (2010) Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 363:1597–1607CrossRefPubMed

Smith CR, Leon MB, Mack MJ et al; PARTNER Trial Investigators (2011) Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med 364:2187–2198CrossRefPubMed

Rodés-Cabau J (2011) Transcatheter aortic valve implantation: current and future approaches. Nat Rev Cardiol 9:15–29CrossRefPubMed

Grube E, Schuler G, Buellesfeld L et al (2007) Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 50:69–76CrossRefPubMed

Grube E, Buellesfeld L, Mueller R et al (2008) Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve revalving system. Circ Cardiovasc Interv 1:167–175CrossRefPubMed

Stokłosa P, Szymański P, Dąbrowski M et al (2015) The impact of transcatheter aortic valve implantation on left ventricular performance and wall thickness––single-centre experience. Postepy Kardiol Interwencyjnej 11:37–43PubMedPubMedCentral

Moat NE, Ludman P, de Belder MA et al (2011) Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the UK TAVI (United Kingdom transcatheter aortic valve implantation) registry. J Am Coll Cardiol 58:2130–2138CrossRefPubMed

Gilard M, Eltchaninoff H, Iung B et al; FRANCE 2 Investigators (2012) Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 366:1705–1715CrossRefPubMed

Nombela-Franco L, Ruel M, Radhakrishnan S et al (2013) Comparison of hemodynamic performance of self-expandable CoreValve vs balloon-expandable Edwards SAPIEN aortic valves inserted by catheter for aortic stenosis. Am J Cardiol 111:1026–1033CrossRefPubMed

10.

Abdel-Wahab M, Comberg T, Büttner HJ et al; Segeberg-Krozingen TAVI Registry (2014) Aortic regurgitation after transcatheter aortic valve implantation with balloon- and self-expandable prostheses: a pooled analysis from a 2-center experience. JACC Cardiovasc Interv 7:284–292CrossRefPubMed

11.

Chang HH, Chen IM, Chen PL, Hsu TL, Lin SM, Chen YH (2015) Comparison of balloon-expandable valves versus self-expandable valves in high-risk patients undergoing transcatheter aortic valve replacement for severe aortic stenosis. J Chin Med Assoc 78:331–338CrossRefPubMed

12.

Kasel AM, Cassese S, Ischinger T et al (2014) A prospective, non-randomized comparison of SAPIEN XT and CoreValve implantation in two sequential cohorts of patients with severe aortic stenosis. Am J Cardiovasc Dis 4:87–99PubMedPubMedCentral

13.

Godino C, Maisano F, Montorfano M et al (2010) Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience. JACC Cardiovasc Interv 3:1110–1121CrossRefPubMed

14.

Vahanian A, Alfieri O, Andreotti F et al (2012) Guidelines on the management of valvular heart disease (version 2012). Eur Heart J 33:2451–2496CrossRefPubMed

15.

Kasel AM, Cassese S, Bleiziffer S et al (2013) Standardized imaging for aortic annular sizing: implications for transcatheter valve selection. JACC Cardiovasc Imaging 6:249–262CrossRefPubMed

16.

Evangelista A, Flachskampf F, Lancellotti P et al (2008) European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies. Eur J Echocardiogr 9:438–448CrossRefPubMed

17.

Hahn RT, Abraham T, Adams MS et al (2013) Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. J Am Soc Echocardiogr 26:921–964CrossRefPubMed

18.

Clavel MA, Rodés-Cabau J, Dumont E et al (2011) Validation and characterization of transcatheter aortic valve effective orifice area measured by Doppler echocardiography. JACC Cardiovasc Imaging 4:1053–1062CrossRefPubMed

19.

Zamorano JL, Badano LP, Bruce C et al (2011) EAE/ASE recommendations for the use of echocardiography in new transcatheter interventions for valvular heart disease. J Am Soc Echocardiogr 24:937–965CrossRefPubMed

20.

Pibarot P, Dumesnil JG (2012) Doppler echocardiographic evaluation of prosthetic valve function. Heart 98:69–78CrossRefPubMed

21.

Zoghbi WA, Chambers JB, Dumesnil JG et al (2009) Recommendations for evaluation of prosthetic valves with echocardiography and Doppler ultrasound. J Am Soc Echocardiogr 22:975–1014CrossRefPubMed

22.

Spethmann S, Dreger H, Schattke S et al (2012) Doppler haemodynamics and effective orifice areas of Edwards SAPIEN and CoreValve transcatheter aortic valves. Eur Heart J Cardiovasc Imaging 13:690–696CrossRefPubMed

23.

Tanrıverdi Z, Dursun H, Kaya D (2015) Comparison of echocardiographic results of CoreValve versus Edwards SAPIEN valves in patients with bicuspid aortic valve. Catheter Cardiovasc Interv. doi:10.1002/ccd.26052 PubMed

24.

Athappan G, Patvardhan E, Tuzcu EM et al (2013) Incidence, predictors, and outcomes of aortic regurgitation after transcatheter aortic valve replacement: meta-analysis and systematic review of literature. J Am Coll Cardiol 61:1585–1595CrossRefPubMed

25.

Généreux P, Head SJ, Wood DA et al (2012) Transcatheter aortic valve implantation: 10-year anniversary part II: clinical implications. Eur Heart J 33:2399–2402CrossRefPubMed

26.

Hahn RT, Kodali S, Généreux P et al (2014) Paravalvular regurgitation following transcutaneous aortic valve replacement: predictors and clinical significance. Curr Cardiol Rep 16:475CrossRefPubMed

27.

Lerakis S, Hayek SS, Douglas PS (2013) Paravalvular aortic leak after transcatheter aortic valve replacement: current knowledge. Circulation 127:397–407CrossRefPubMed

28.

Dvir D, Barbash IM, Ben-Dor I et al (2013) Paravalvular regurgitation after transcatheter aortic valve replacement: diagnosis, clinical outcome, preventive and therapeutic strategies. Cardiovasc Revasc Med 14:174–181CrossRefPubMed

29.

Abdel-Wahab M, Mehilli J, Frerker C et al; CHOICE investigators (2014) Comparison of balloon-expandable vs self-expandable valves in patients undergoing transcatheter aortic valve replacement: the CHOICE randomized clinical trial. JAMA 311:1503–1514CrossRefPubMed

30.

O’Sullivan KE, Gough A, Segurado R et al (2014) Is valve choice a significant determinant of paravalvular leak post-transcatheter aortic valve implantation? A systematic review and meta-analysis. Eur J Cardiothorac Surg 45:826–833CrossRefPubMed

31.

Zegdi R, Lecuyer L, Achouh P et al (2010) Increased radial force improves stent deployment in tricuspid but not in bicuspid stenotic native aortic valves. Ann Thorac Surg 89:768–772CrossRefPubMed

32.

Tzamtzis S, Viquerat J, Yap J et al (2013) Numerical analysis of the radial force produced by the Medtronic-CoreValve and Edwards-SAPIEN after transcatheter aortic valve implantation (TAVI). Med Eng Phys 35:125–130CrossRefPubMed

33.

Jilaihawi H, Chin D, Spyt T et al (2010) Prosthesis-patient mismatch after transcatheter aortic valve implantation with the Medtronic CoreValve bioprosthesis. Eur Heart J 31:857–864CrossRefPubMed

34.

Ali OF, Schultz C, Jabbour A et al (2015) Predictors of paravalvular aortic regurgitation following self-expanding Medtronic CoreValve implantation: the role of annulus size, degree of calcification, and balloon size during pre-implantation valvuloplasty and implant depth. Int J Cardiol 179:539–545CrossRefPubMed

35.

Abdel-Wahab M, Zahn R, Horack M et al (2011) Aortic regurgitation after transcatheter aortic valve implantation: incidence and early outcome. Results from the German transcatheter aortic valve interventions registry. Heart 97:899–906CrossRefPubMed

36.

Tagaki K, Latib A, Al-Lamee R et al (2011) Predictors of moderate-to-severe paravalvular aortic regurgitation immediately after CoreValve implantation and the impact of postdilatation. Catheter Cardiovasc Interv 78:432–443

37.

Bleiziffer S, Mazzitelli D, Opitz A et al (2012) Beyond the short-term: clinical outcome and valve performance 2 years after transcatheter aortic valve implantation in 227 patients. J Thorac Cardiovasc Surg 143:310–317CrossRefPubMed

38.

Kodali SK, Williams MR, Smith CR et al (2012) Two-year outcomes after transcatheter or surgical aortic valve replacement. N Engl J Med 366:1686–1695CrossRefPubMed

39.

Kapadia SR, Tuzcu EM, Makkar RR et al (2014) Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapy. Circulation 130:1483–1492CrossRefPubMed

40.

Gurvitch R, Webb JG, Yuan R et al (2011) Aortic annulus diameter determination by multidetector computed tomogra-phy: reproducibility applicability and implications for transcatheter aortic valve implantation. JACC Cardiovasc Interv 4:1235–1245CrossRefPubMed

41.

Toggweiler S, Humphries KH, Lee M et al (2013) 5-year outcome after transcatheter aortic valve implantation. J Am Coll Cardiol 61:413–419CrossRefPubMed

Title: Echocardiographic outcomes of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN XT valves: the comparison of two bioprosthesis implanted in a single centre
Authors: Dayimi Kaya
Zulkif Tanriverdi
Huseyin Dursun
Tugce Colluoglu
Publication date: 01-09-2016
Publisher: Springer Netherlands
Published in: The International Journal of Cardiovascular Imaging / Issue 9/2016
Print ISSN: 1569-5794
Electronic ISSN: 1875-8312
DOI: https://doi.org/10.1007/s10554-016-0924-y

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Echocardiographic outcomes of self-expandable CoreValve versus balloon-expandable Edwards SAPIEN XT valves: the comparison of two bioprosthesis implanted in a single centre

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 9/2016

Feasibility of ultra low-dose thallium stress-redistribution protocol including prone imaging in obese patients using CZT camera

12-month intravascular ultrasound observations from BiOSS® first-in-man studies

Cardiovascular magnetic resonance features of mechanical dyssynchrony in patients with left bundle branch block

Application of computed tomographic virtual vascular intraluminal endoscopy

Morphological and functional abnormalities pattern in hypertrophy-free HCM mutation carriers detected with echocardiography

Optical coherence tomography assessment ruled out the need for intervention in a ‘hazy’ angiographic image

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page